Bios Equity Partners II, LP - Insider Non-Derivative Transactions at Lantern Pharma Inc. (LTRN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 17, 2024, Bios Equity Partners II, LP's relationship to Lantern Pharma Inc. (LTRN) is TenPercentOwner, and currently has 591,036 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LTRN insiders.
Data Source: SEC.
Bios Equity Partners II, LP - Insider Non-Derivative Transactions at LTRN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 18, 2024 | Sell -- (Common Stock) | 5475 | 4.2 | 73646 |
| Jan 18, 2024 | X -- (Common Stock) | 7347 | 3.13 | 79121 |
| Jan 18, 2024 | Sell -- (Common Stock) | 12521 | 4.2 | 168417 |
| Jan 18, 2024 | X -- (Common Stock) | 16801 | 3.13 | 180938 |
| Jan 18, 2024 | Sell -- (Common Stock) | 40893 | 4.2 | 550143 |
| Jan 18, 2024 | X -- (Common Stock) | 54873 | 3.13 | 591036 |